⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3341032 | 1.00 | — | — | |
| SCHEMBL30070965 | 0.86 | — | — | |
| SCHEMBL474365 | 0.86 | — | — | |
| SCHEMBL852469 | 0.83 | L3MBTL1 (0.35) | — | |
| SCHEMBL25316899 | 0.82 | — | — | |
| SCHEMBL4533845 | 0.82 | — | — | |
| SCHEMBL25315905 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL29539199 | 0.78 | L3MBTL1 (0.55) | — | |
| SCHEMBL18207911 | 0.78 | L3MBTL1 (0.37) | — | |
| Carbamic Acid SCHEMBL16347434 | 0.78 | SLC1A2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2076879-A | — | — | None | — | — | JP | disclosed |
| JP-4270283-A | — | — | None | — | — | JP | disclosed |
| EP-4223761-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-08-09 | — | — | EP | disclosed |
| US-9062057-B2 | CCR5 antagonists for treating HIV | PURDUE RESEARCH FOUNDATION (US) | 2015-06-23 | — | — | US | disclosed |
| US-9062057-B2 | CCR5 antagonists for treating HIV | PURDUE RESEARCH FOUNDATION (US) | 2015-06-23 | — | — | US | disclosed |
| US-20140221420-A1 | CCR5 ANTAGONISTS FOR TREATING HIV | PURDUE RESEARCH FOUNDATION (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140221420-A1 | CCR5 ANTAGONISTS FOR TREATING HIV | PURDUE RESEARCH FOUNDATION (US) | 2014-08-07 | — | — | US | disclosed |
| CN-102086201-A | Method for quickly synthesizing cis-octahydropyrrolo[3,2-b]pyrrole | WUXI APP INC | 2011-06-08 | — | — | CN | disclosed |
| CN-102086201-A | Method for quickly synthesizing cis-octahydropyrrolo[3,2-b]pyrrole | WUXI APP INC | 2011-06-08 | — | — | CN | disclosed |
| CN-102086202-A | Method for quickly preparing cis-octahydropyrrolo[3,2-b]pyrrole | WUXI APP INC | 2011-06-08 | — | — | CN | disclosed |
| CN-102086202-A | Method for quickly preparing cis-octahydropyrrolo[3,2-b]pyrrole | WUXI APP INC | 2011-06-08 | — | — | CN | disclosed |
| US-7838528-B2 | Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2010-11-23 | — | — | US | disclosed |
| US-20100144700-A1 | HETEROCYCLIC-CARBONYL-DIAZABICYCLOALKANES AS MODULATORS OF THE NEURONAL NICOTINIC ACETYLCHOLINE ALPHA 4 BETA 2, SUBTYPE RECEPTOR FOR THE TREATMENT OF CNS RELATED DISORDERS | TARGACEPT, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-20070167468-A1 | SUBSTITUTED BICYCLIC 8-PYRR0LIDINOXANTHINES, METHODS FOR THEIR PRODUCTION, PHARMACEUTICAL FORMULATIONS AND THEIR USE | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-19 | — | — | US | disclosed |
| EP-1776372-A1 | SUBSTITUTED, BICYCLIC 8-PYRROLIDINOXANTHINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | Sanofi-Aventis Deutschland GmbH (DE) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006015701-A1 | SUBSTITUTED, BICYCLIC 8-PYRROLIDINOXANTHINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-02-16 | — | — | WO | disclosed |
| JP-H04270283-A | CIS-2,6-DIAZABICYCLO(3.3.0)OCTANE DERIVATIVE | YOSHITOMI PHARMACEUT IND LTD | 1992-09-25 | — | — | JP | disclosed |
| JP-H0276879-A | CIS-2,6-DIAZABICYCLO(3.3.0)OCTANE DERIVATIVE AND USE APPLICATION THEREOF AS MEDICINE | YOSHITOMI PHARMACEUT IND LTD | 1990-03-16 | — | — | JP | disclosed |
| WO-1989012048-A1 | CIS-2,6-DIAZABICYCLO[3.3.0]OCTANE DERIVATIVES AND THEIR MEDICINAL USE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-12-14 | — | — | WO | disclosed |
| WO-1989012048-A1 | CIS-2,6-DIAZABICYCLO[3.3.0]OCTANE DERIVATIVES AND THEIR MEDICINAL USE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-12-14 | — | — | WO | disclosed |